Clover Health Investments... (CLOV)
Clover Health Investments Statistics
Share Statistics
Clover Health Investments has 510.91M shares outstanding. The number of shares has increased by 2.91% in one year.
| Shares Outstanding | 510.91M |
| Shares Change (YoY) | 2.91% |
| Shares Change (QoQ) | 1.96% |
| Owned by Institutions (%) | 18.94% |
| Shares Floating | 467.75M |
| Failed to Deliver (FTD) Shares | 60 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 12.04M, so 2.4% of the outstanding shares have been sold short.
| Short Interest | 12.04M |
| Short % of Shares Out | 2.4% |
| Short % of Float | 2.97% |
| Short Ratio (days to cover) | 2.72 |
Valuation Ratios
The PE ratio is -35.89 and the forward PE ratio is -36. Clover Health Investments's PEG ratio is 0.44.
| PE Ratio | -35.89 |
| Forward PE | -36 |
| PS Ratio | 1.13 |
| Forward PS | 0.6 |
| PB Ratio | 4.52 |
| P/FCF Ratio | 46.37 |
| PEG Ratio | 0.44 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Clover Health Investments.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.
| Current Ratio | 1.61 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $2.41M |
| Profits Per Employee | $-75.45K |
| Employee Count | 570 |
| Asset Turnover | 2.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 466.39% in the last 52 weeks. The beta is 2, so Clover Health Investments's price volatility has been higher than the market average.
| Beta | 2 |
| 52-Week Price Change | 466.39% |
| 50-Day Moving Average | 3.86 |
| 200-Day Moving Average | 3.31 |
| Relative Strength Index (RSI) | 47.05 |
| Average Volume (20 Days) | 6.07M |
Income Statement
In the last 12 months, Clover Health Investments had revenue of 1.37B and earned -43.01M in profits. Earnings per share was -0.08.
| Revenue | 1.37B |
| Gross Profit | 364.8M |
| Operating Income | -45.75M |
| Net Income | -43.01M |
| EBITDA | -44.94M |
| EBIT | -46.27M |
| Earnings Per Share (EPS) | -0.08 |
Balance Sheet
The company has 194.54M in cash and 0 in debt, giving a net cash position of 194.54M.
| Cash & Cash Equivalents | 194.54M |
| Total Debt | 0 |
| Net Cash | 194.54M |
| Retained Earnings | -2.2B |
| Total Assets | 580.74M |
| Working Capital | 129.61M |
Cash Flow
In the last 12 months, operating cash flow was 34.84M and capital expenditures -1.56M, giving a free cash flow of 33.29M.
| Operating Cash Flow | 34.84M |
| Capital Expenditures | -1.56M |
| Free Cash Flow | 33.29M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 26.61%, with operating and profit margins of -3.34% and -3.14%.
| Gross Margin | 26.61% |
| Operating Margin | -3.34% |
| Pretax Margin | -3.37% |
| Profit Margin | -3.14% |
| EBITDA Margin | -3.28% |
| EBIT Margin | -3.34% |
| FCF Margin | 2.43% |
Dividends & Yields
CLOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CLOV is $4.5, which is 25% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.5 |
| Price Target Difference | 25% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 5 |